🚀 VC round data is live in beta, check it out!
Shanghai C&D Innostic Valuation Multiples
Discover revenue and EBITDA valuation multiples for Shanghai C&D Innostic and similar public comparables like CAC Nantong Chemical Co, RHI Magnesita, Solvac, Lanxess and more.
Shanghai C&D Innostic Overview
About Shanghai C&D Innostic
Shanghai C and D Innostic Medical Technology Group Co Ltd is engaged in Direct sales and distribution of medical devices, and provision of services such as intensive operation of medical consumables (SPD) to terminal hospitals.
Founded
2010
HQ
Employees
N/A
Website
Sectors
Financials (FY)
EV
$2B
Shanghai C&D Innostic Financials
Shanghai C&D Innostic reported last fiscal year revenue of $3B and EBITDA of $99M.
In the same fiscal year, Shanghai C&D Innostic generated $227M in gross profit, $99M in EBITDA, and $40M in net income.
Revenue (LTM)
Shanghai C&D Innostic P&L
In the most recent fiscal year, Shanghai C&D Innostic reported revenue of $3B and EBITDA of $99M.
Shanghai C&D Innostic expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $3B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $227M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA | — | XXX | $99M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 3% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 4% | XXX | XXX | XXX |
| Net Profit | — | XXX | $40M | XXX | XXX | XXX |
| Net Margin | — | XXX | 1% | XXX | XXX | XXX |
| Net Debt | — | — | $235M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Shanghai C&D Innostic Stock Performance
Shanghai C&D Innostic has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
Shanghai C&D Innostic's stock price is $4.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.6% | XXX | XXX | XXX | $0.09 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialShanghai C&D Innostic Valuation Multiples
Shanghai C&D Innostic trades at 0.7x EV/Revenue multiple, and 20.5x EV/EBITDA.
EV / Revenue (LTM)
Shanghai C&D Innostic Financial Valuation Multiples
As of April 21, 2026, Shanghai C&D Innostic has market cap of $2B and EV of $2B.
Equity research analysts estimate Shanghai C&D Innostic's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Shanghai C&D Innostic has a P/E ratio of 44.0x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV (current) | $2B | XXX | $2B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.7x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 20.5x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 19.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 9.0x | XXX | XXX | XXX |
| P/E | — | XXX | 44.0x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 20.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Shanghai C&D Innostic Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Shanghai C&D Innostic Margins & Growth Rates
Shanghai C&D Innostic's revenue in the last fiscal year grew by 8%.
Shanghai C&D Innostic Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 8% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 3% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (23%) | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 1% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 4% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Shanghai C&D Innostic Public Comps
See public comps and valuation multiples for other Chemicals comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Shanghai C&D Innostic | XXX | XXX | XXX | XXX | XXX | XXX |
| CAC Nantong Chemical Co | XXX | XXX | XXX | XXX | XXX | XXX |
| RHI Magnesita | XXX | XXX | XXX | XXX | XXX | XXX |
| Solvac | XXX | XXX | XXX | XXX | XXX | XXX |
| Lanxess | XXX | XXX | XXX | XXX | XXX | XXX |
| Saudi Chemical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Shanghai C&D Innostic M&A Activity
Shanghai C&D Innostic acquired XXX companies to date.
Last acquisition by Shanghai C&D Innostic was on XXXXXXXX, XXXXX. Shanghai C&D Innostic acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Shanghai C&D Innostic
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialShanghai C&D Innostic Investment Activity
Shanghai C&D Innostic invested in XXX companies to date.
Shanghai C&D Innostic made its latest investment on XXXXXXXX, XXXXX. Shanghai C&D Innostic invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Shanghai C&D Innostic
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Shanghai C&D Innostic
| When was Shanghai C&D Innostic founded? | Shanghai C&D Innostic was founded in 2010. |
| Where is Shanghai C&D Innostic headquartered? | Shanghai C&D Innostic is headquartered in China. |
| Is Shanghai C&D Innostic publicly listed? | Yes, Shanghai C&D Innostic is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of Shanghai C&D Innostic? | Shanghai C&D Innostic trades under 301584 ticker. |
| When did Shanghai C&D Innostic go public? | Shanghai C&D Innostic went public in 2025. |
| Who are competitors of Shanghai C&D Innostic? | Shanghai C&D Innostic main competitors are CAC Nantong Chemical Co, RHI Magnesita, Solvac, Lanxess. |
| What is the current market cap of Shanghai C&D Innostic? | Shanghai C&D Innostic's current market cap is $2B. |
| What is the current revenue of Shanghai C&D Innostic? | Shanghai C&D Innostic's last fiscal year revenue is $3B. |
| What is the current EV/Revenue multiple of Shanghai C&D Innostic? | Current revenue multiple of Shanghai C&D Innostic is 0.7x. |
| Is Shanghai C&D Innostic profitable? | No, Shanghai C&D Innostic is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.